ANTIBIOTIC RESISTANCE: Biofilm Dispersing Agent Rejuvenates Older Antibiotics by Potera, Carol
A human being is a whole world to a mitochondrion, just the way our 
planet is to us. But we’re much more dependent on our mitochondria than 
the earth is on us.
Madeleine L’Engle, A Wind in the Door (1973)
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Antibiotic resistAnce
biofilm Dispersing 
Agent rejuvenates 
older Antibiotics
An estimated 75% of bacterial infections 
involve biofilms, surface-attached colonies 
of bacteria that are protected by an extra-
cellular matrix.
1 Bacteria protected within 
biofilms are up to 1,000 times more resis-
tant to antibiotics than if they were free-
floating (planktonic),
2 which severely com-
plicates  treatment  options.  Rather  than 
searching  for  better  anti  biotics,  research-
ers have discovered that small molecules
3 
known as 2-amino-imidazoles disrupt bio-
films, making antibiotic-resistant strains of 
bacteria more vulnerable to conventional 
drugs.
4 Moreover, antibiotics enhance the 
ability  of  2-amino-imidazoles  to  disrupt 
biofilms. “Perhaps new antibiotics are not 
the  only  way  to  combat  biofilm  infec-
tions  if  we  could  make  ineffective  older 
anti  biotics  active  again,”  says  principal 
investigator Christian Melander, an associ-
ate professor of bio-organic chemistry at 
North Carolina State University.
Melander  and  his  colleagues  started 
with natural 2-amino-imidazoles (isolated 
from sponges) including oroidin and age-
liferin, which are known to block biofilm 
formation. They synthesized an improved 
version  of  oroidin,  2-amino-imidazole/
triazole  (2-AIT),  which  featured  more 
powerful  antibiofilm  activity  and  less 
toxicity to surrounding human cells and 
organs.
5 Although 2-AIT alone does not 
kill bacteria, it disperses biofilms, releasing 
planktonic cells that are more susceptible 
to antibiotics than bacterial cells shielded 
by sticky biofilms.
The researchers tested 2-AIT against 
a  variety  of  clinically  relevant  biofilm 
infections along with antibiotics that cur-
rently are used or have been used in the 
past  to  treat  them.  Multidrug-resistant 
strains of Acinetobacter baumannii plague 
soldiers  wounded  in  the  Middle  East, 
and  colistin,  an  older  antibiotic  with 
toxic side effects, remains a treatment of 
last resort due to extensive side effects.
6 
Staphylococcus  aureus  infections  that 
colonize  catheters  and  other  indwelling 
medical  devices  were  treated  with  the 
antibiotic novobiocin until drug-resistant 
S. aureus strains arose.
7 Tobramycin is an 
inhaled antibiotic currently used to treat 
Pseudomonas  aeruginosa  infections  that 
clog the lungs of cystic fibrosis patients.
8 
“We  chose  three  antibiotics  known  to 
act against certain bacteria circulating in 
hospital settings that have become drug 
resistant,” says Melander.
The biofilms were grown in culture, 
then  treated  with  their  corresponding 
antibiotic, all of which produced little dis-
persion. However, the addition of 2-AIT to 
the antibiotics produced dramatic disper-
sion of up to 1,000-fold.
4 Like adjuvants 
that boost the power of vaccines, 2-AIT is 
“our version of a small molecule adjuvant 
that allows several classes of older antibi-
otics to work again,” says Melander. He 
suspects  2-AIT  somehow  short-circuits 
bacterial signaling pathways that regulate 
biofilm formation; experiments are under 
way to unravel the details.
2-AIT  also  was  shown  to  resensitize 
drug-resistant bacteria to death by anti-
biotic. When a clinical strain of methicil-
lin-resistant S. aureus (MRSA) was treated 
with 2-AIT alone, it grew normally. The 
addition of methicillin, however, reduced 
its growth by 99%. Additionally, 2-AIT 
lowered the amount of antibiotics needed 
to inhibit bacterial growth.
4 
The combination of 2-AIT with anti­
biotics  could  serve  as  a  parallel  treat-
ment  for  antibiotic-resistant  infections. 
The  results  suggest  this  cooperative 
approach may enable “obsolete antibiotics 
to  overcome  infections  that  otherwise 
would persist if treated with either agent 
individually,”  says  Melander.  A  small 
molecule adjuvant like 2-AIT potentially 
could be given orally in 
pill form, he says.
2-AIT “most remark-
ably can actually disperse 
preformed  biofilms, 
something that is much 
more difficult to do than 
simply  inhibiting  their 
formation,” says Neville 
Kallenbach, a professor 
of chemistry at New York 
University in New York 
City.  Because  biofilms 
are  much  harder  to  kill 
than planktonic bacteria, 
the combination therapy 
opens a new avenue for 
remediating  persistent 
biofilm infections. “The 
ability  to  disperse  bio-
films formed by multidrug-resistant bacteria 
adds  a  major  new  weapon  to  the  limited 
arsenal  of  therapies  available  today,”  says 
Kallenbach—and  the  impact  on  human 
health could be enormous.
Agents such as 2-AIT also lend them-
selves  to  solving  environmental  biofilm 
problems  including  the  biofouling  of 
ship  hulls  and  plugging  of  waterlines 
by microbes such as Escherichia coli and 
Bacillus,  Pseudomonas,  Proteobacter,  and 
Actinobacteria species. Today’s antifouling 
paints contain copper, which leaches into 
seawater, where it inhibits enzymatic activ-
ity  in  brine  shrimp  larvae
9  and  impairs 
sperm  quality  and  larvae  development 
in  sea  urchins,
10  among  other  effects. 
Melander  is  working  on  a  copper-free 
2-AIT-based  polymer  spray  to  prevent 
biofouling. 
Carol Potera, based in Montana, has written for EHP since 
1996. She also writes for Microbe, Genetic Engineering News, 
and the American Journal of Nursing.
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chemicAl exposures
more iodine or 
less perchlorate?
Perchlorate  is  believed  to  block  uptake  of 
iodine into the thyroid, eventually resulting in 
the decreased production of the thyroid hor-
mones thyroxine and triiodothyronine. But a 
science review of perchlorate concludes that 
reducing the risk of mental deficits in children 
whose mothers are exposed to the chemical 
may be achieved most efficiently by correcting 
the iodine deficiency that occurs in roughly a 
third of U.S. women of child-bearing age—
not by reducing perchlorate intake.
1 
The review is a first for the U.S. Environ-
mental  Protection  Agency  (EPA)  Office  of 
Inspector  General  (OIG),  which  primarily 
conducts audits, evaluations, and investiga-
tions of the EPA and its contractors to pro-
mote economy and efficiency, and to prevent 
and  detect  fraud,  waste,  and  abuse.  But 
rather than resolving controversy over the risk 
characterization  of  perchlorate,  the  review 
appears instead to be further fueling it.
2
In comments offered in response to the 
review, the Environmental Working Group 
wrote  that  the  OIG  had  used  the  review 
to  justify  their  endorsement  of  the  Bush 
Administration’s  failure  to  set  a  drinking 
water  standard  perchlorate,  which  pollutes 
the drinking water of an estimated 20–40 
million  people  nationwide.
3  But  Purnendu 
Dasgupta,  an  analytical  chemist  at  the 
University of Texas, Arlington, applauds the 
OIG for stepping in to address a major public 
health gap. “The continued brouhaha about 
perchlorate  alone,  whether  by  activists  or 
protectionists, merely acts as a smokescreen,” 
he  says.  “We  have  urgent  problems  about 
iodine  nutrition;  the  preoccupation  with 
perchlorate alone is obscuring the fact that 
we are gambling with the intellectual future 
of the next generation at our peril.”
Perchlorate is thought to affect thyroid 
function by blocking uptake of iodine, an 
essential  component  of  thyroid  hormones, 
which orchestrate brain development. Other 
chemicals—in particular, thiocyanate (found 
in tobacco smoke and cruciferous vegetables) 
and nitrate (found in leafy vegetables, pro-
cessed meats, and some contaminated water 
supplies)—act  in  a  similar  way.  Too  little 
iodide  also  has  the  same  effect.  The  OIG 
considered  all  four  of  these  factors  in  its 
cumulative risk assessment, a type of assess-
ment  that  looks  at  the  public  health  risk 
arising from multiple, combined stressors. 
By attempting a more holistic cumula-
tive assessment, OIG says it is at the van-
guard of governmental agencies in follow-
ing  recommendations  from  several  recent 
governmental advisory committees.
2 House 
and Senate draft versions of chemical regula-
tion  reform  bills  also  call  for  cumulative 
risk assessments. Risk assessment specialists 
generally applaud this innovative aspect of 
the OIG effort. But many comments on the 
report referred to the lack of peer review, 
failure to consider major studies, failure to 
specifically consider the risk of perchlorate 
exposure to infants, and an excessive reli-
ance on one in vitro study
4 that estimated 
the relative potencies of the different thyroid 
stressors in terms of their ability to block 
iodine uptake.
The OIG hired consultancy ICF Inter-
national  to  conduct  a  technical  review  of 
the  assessment.  ICF  International  broadly 
endorsed the OIG’s cumulative risk assess-
ment approach, but recommended the use 
of more recent peer-reviewed human stud-
ies, in particular a 2006 study
5 that found a 
statistically significant association between 
changes  in  thyroid  function  to  levels  of 
perchlorate  exposure  roughly  an  order  of 
magnitude  lower  than  those  in  previous 
studies of people exposed to perchlorate. 
The  Environmental  Working  Group 
contends  ICF  International  had  a  poten-
tial  conflict  of  interest  because  the  firm 
has consulted for federal agencies, military 
contractors,  and  other  entities  responsible 
for perchlorate pollution in drinking water 
supplies,  all  of  whom  “have  vigorously 
opposed strong public health standards for 
perchlorate.”
3  The  Massachusetts  Depart-
ment  of  Environmental  Protection  raised 
similar  concerns.  But  the  OIG  contends 
ICF International was selected as the best 
qualified bidder under federal guidelines.
2
Other  questions  revolve  around  data 
suggesting perchlorate may have additional 
mechanisms  of  action  beyond  its  ability 
to  inhibit  iodine  uptake.
6  “Although  the 
OIG study is informative with respect to 
cumulative impacts at the level of thyroidal 
iodine  uptake,  the  potential  existence  of 
additional  mechanisms  of  action  should 
temper  conclusions  regarding  appropriate 
perchlorate exposure limits, especially where 
the iodine uptake inhibition estimates are 
derived  from  an  in  vitro  model that does 
not reflect the complexity of in vivo thyroid 
function, effects, and responses,” says toxi-
cologist C. Mark Smith of the Massachusetts 
Department of Environmental Protection.
Adam Finkel, a member of the National 
Research Council committee that evaluated 
EPA risk assessment protocols,
7 notes more-
over that cumulative risk assessments such 
as this could end up yielding questionable 
policy.  “Advocates  for  holistic  risk  assess-
ments assumed the point to be that you can 
make a stronger case for reducing pollutant 
X if you see it in context of all the other 
things also adding to the burden of disease 
Y—but this report turns that logic on its 
head and says essentially that when you see 
the whole picture, you see a reason to ignore 
the pollutant and work on the other things,” 
he explains.
The conclusions of the review conflict 
with  risk  assessments  conducted  by  states 
such as California and Massachusetts, which 
have adopted health recommendations more 
stringent  than  the  current  EPA  reference 
dose for perchlorate of 0.0007 mg/kg/day 
(total  intake  from  both  water  and  food). 
“Although improving iodine nutrition is an 
important public health issue itself, it is an 
incomplete response to perchlorate drinking 
water contamination,” Smith says. “Infants 
are the population of greatest concern iden-
tified in the Massachusetts risk assessment, 
but the OIG assessment doesn’t adequately 
address  their  demonstrated  potential  for 
significant perchlorate exposure and risk.”  
“It’s  great  that  this  cumulative  assess-
ment  looks  more  broadly  and  seeks  to 
consider possible risk management solutions 
early in the assessment process,” says Finkel. 
“But while adding iodide may be the most 
efficient  solution,  that  is  not  for  the  risk 
assessor to prejudge—we need a document 
that lays out the costs and benefits of alter-
native approaches, not one that trivializes 
the environmental risk because there may be 
a ‘supply side’ way of sidestepping it.” 
Jonathan Levy, who also was a member 
of the panel that evaluated EPA risk assess-
ment protocols,
7 agrees. “Our NAS commit-
tee recommendations would argue that the 
presence of multiple stressors would imply 
that health effects would be anticipated at 
low dose of perchlorate,” he says. “The fact 
that other stressors have greater effects is an 
interesting  observation,  but  we  explicitly 
stated that this should not be the primary 
output of cumulative risk assessment.”
Rebecca Renner, PhD, of Williamsport, PA, is a long-time 
contributor to EHP and Environmental Science & Technology. 
Her work has also appeared in Scientific American, Science, 
and Salon.com.
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EWG Issues 2010 Sunscreen Guide
In its fourth report on sunscreen products, the 
Environmental Working Group recommends only 
8% of 500 products tested.1 The group reports 
a surge in products boasting an SPF higher 
than 50, “which sell a false sense of security” 
since higher SPF does not necessarily equate to 
more protection. Several products contained 
ingredients of potential health concern: retinyl 
palmitate, which has been linked to accelerated 
development of skin tumors and lesions, was 
found in 41% of sunscreens assessed, and 
oxybenzone, an endocrine-disrupting compound, 
was found in 60%.
EPA Exposure Assessment: PBDEs
A new EPA exposure assessment2 shows that 
U.S. exposure to polybrominated diphenyl ethers 
(PBDEs) occurs primarily through house dust, 
unlike other persistent organic pollutants, which 
typically are encountered in food. Additionally, 
weight-specific intake rates are higher for U.S. 
children, especially infants, than for adults. 
The EPA is planning to issue new rules later 
this year for the manufacture and import of 
products containing two specific PBDEs. PBDE 
flame retardants, some of which have already 
been phased out of commerce, are used in 
applications including furniture and electronics.
“Safer” Cigarettes Still Hazardous
Smoking tobacco- and nicotine-free cigarettes 
made of lettuce may be at least as hazardous 
as smoking conventional tobacco cigarettes, 
if not more so. In a study of the supposedly 
safer cigarettes, which were introduced in 1997, 
dose-dependent double-strand DNA breaks 
were seen after shorter durations of exposure to 
smoke compared with conventional cigarettes.3 
The Beat | by Erin E. Dooley
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First combined Analysis 
from interphone 
inconclusive 
Long-awaited results of the largest effort yet to investigate whether 
cell  phone  use  contributes  to  brain  cancers  are  finally  available.
1 
But the May report, the first combined analysis of results from the 
International Agency for Research on Cancer’s (IARC) $24-million 
INTERPHONE study, is inconclusive, stating that “suggestions of an 
increased risk of glioma at the highest exposure levels, but biases and 
errors prevent a causal interpretation.” 
The  interview-based  case–control  INTERPHONE  study  was 
the collaborative effort of 48 researchers from 13 nations. It began 
in 2000 and included more than 14,000 participants, among them 
2,765 glioma and 2,425 meningioma cases and matched controls2 (the 
current analysis included 2,708 glioma and 2,409 menin  gioma cases).
No other studies have included as many exposed cases, particularly of 
long-term and heavy users of cell phones.
A major challenge the researchers faced in interpreting the data 
was the high refusal rates among controls—that is, controls were 
successfully contacted but declined to give the information sought—
says the study’s principal investigator, Elisabeth Cardis, now of the 
Centre for Research in Environmental Epidemiology in Barcelona, 
Spain. “This resulted in mobile phone users being overrepresented 
among controls,” Cardis explains. The vast majority of the study’s 
risk estimates are below 1, which suggests there might have been a 
selection bias in amassing the study population, she says. 
Additionally, cell phone usage patterns have changed significantly 
in the decade since INTERPHONE began. “Most of the users in the 
study had relatively low use compared to today’s use,” Cardis points 
out. The usage by people in the study’s highest cumulative call time 
group corresponds to about half an hour a day for a period of 10 years 
or more, which is “pretty normal or even light use today,” she says. 
At the same time, concerns over recall bias also made the data hard 
to interpret. For example, some cases—but no controls—claimed to 
spend 12 or more hours a day on their cell phone.
Besides  the  brain  tumors  assessed  in  the  current  study, 
INTERPHONE also evaluated correlations between cell phone use 
and tumors of the acoustic nerve and the parotid salivary gland. These 
two tumor types will be the focus of future reports, Cardis says.
The  period  of  exposure  for  all  of  the  subjects  included  in 
INTERPHONE is relatively short for assessing a causative link to a 
cancer,  according  to  a  commentary  published  alongside  the  study.
3 
Cell  phone  use  began  in  the  1980s  but  was  not  widespread  until 
the  mid-1990s,  wrote  authors  Rodolfo  Saracci  of  Italy’s  National 
Research  Council  in  Pisa  and  Jonathan  Samet  of  the  University  of 
Southern  California’s  Department  of  Preventive  Medicine.  “None 
of . . . today’s established carcinogens, including tobacco, could have 
been firmly identified as increasing risk in the first 10 years or so since 
In the most recent industry figures from CTIA,
7 U.S. cell phone users 
logged about 2.3 trillion minutes of use per year, but many users 
are reporting an increase in text messages over calls.
Contrary to public perception, there is no 
evidence sunscreen prevents skin cancer.
“Safer” cigarettes? 
Nice try, but no cigar.
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The tobacco- and nicotine-free cigarettes also 
delivered far higher doses of total particulate 
matter (“tar”).The researchers used phospho-
specific antibodies to measure DNA damage 
response and their own laser scanning cytometry 
instrumentation, which they say should be a 
useful  complement  to  other  methods  for 
assessing genotoxicity of cigarette smoke.
BPA and Male Sexual Dysunction
Bisphenol A (BPA) is used in a large number of 
consumer products, including plastic containers 
and food and beverage can linings. Following up 
on an earlier study4 comparing workers with and 
without occupational BPA exposure, researchers 
assessed urine BPA levels and sexual function in 
a subset of workers and found that increasing 
urine BPA level was associated with decreasing 
values for seven measures of sexual function.5 An 
additional analysis restricted to workers exposed 
to BPA only nonoccupationally revealed a similar 
trend, but the authors wrote that “many of the 
estimates were no longer statistically significant 
due to the markedly reduced sample size.”
Indoor Tanning and Melanoma: 
Evidence Strengthens
A new study presents strong evidence that 
use of tanning beds may lead to higher odds 
of melanoma.6 Compared with people who 
never  tanned  indoors,  people  using  any 
tanning bed were almost 75% more likely 
to develop melanoma, and frequent users 
of indoor tanning beds had the highest risk. 
The study also showed for the first time that 
melanoma was more strongly associated with 
frequency of tanning than with age at which 
indoor tanning began. Earlier studies showed 
only weak associations with melanoma risk; 
most were unable to adjust for sun exposure 
or did not confirm dose response or compare 
specific tanning devices—gaps bridged in the 
current population-based case–control study. 
Melanoma, the most dangerous form of skin 
cancer, is also one of the fastest increasing 
cancers in the United States.7
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first exposure,” explained Saracci and Samet. “Ionizing radiation is 
a recognized cause of brain tumors, but except for rare instances the 
radiation-induced cases occur on average after 10–20 years since the 
time of first exposure.” The authors conclude, therefore, that “observing 
no increase in risk would be reassuring but only to a limited extent.” 
Publication of the first results from INTERPHONE was origi-
nally expected in 2006. Cardis says the report was delayed because of 
the large research team’s difficulties in interpreting the results. “The 
entire study group and all of the coauthors . . . spent a lot of time 
conducting hundreds of additional analyses, reviewing the analyses, 
and trying to understand the potential biases of the study,” she says. 
“We’ve conducted about every analysis that we could think to do.” 
One of the analyses that did not make it into the main text of the 
report is Appendix 2, which is mentioned in Saracci and Samet’s com-
mentary. Published only online as supplementary material, it presents 
an  alternative  analysis  that  suggests  an  increase  in  glioma  among 
subjects in the top 10% of cumulative call time. The alternative analysis 
compared the incidence of glioma in the most highly exposed subjects 
to that in study subjects who had the lowest amount of exposure among 
regular cell phone users. In contrast, the primary analysis compared the 
incidence of glioma in the highly exposed group to the incidence among 
subjects who reported that they rarely or never used cell phones at all. 
This approach—which accounts for the possibility that cell phone 
radiation exposure is not the only potential risk factor that differs between 
people who regularly use cell phones and people who don’t—is com-
mon in occupational epidemiology. However, some INTERPHONE 
investigators believed the analysis would be inappropriate if the main 
reason  for  the  decreased  odds  ratios  observed  in  the  study  was  not 
selection bias. “We have legitimate differences in the interpretation of 
these results and the value of this analysis,” Cardis says.
IARC director Christopher Wild says, “Observations at the high-
est level of cumulative call time and the changing patterns of mobile 
phone use since the period studied by INTERPHONE, particularly 
in young people, mean that further investigation of mobile phone use 
and brain cancer risk is merited.” John Walls, vice president of public 
affairs for CTIA-The Wireless Association®, which represents the cell 
phone industry, says, “The possible effects of long-term heavy use of 
mobile phones require further investigation.”
Three important new studies are already under way to collect more 
data. The first is an animal study being conducted by the National 
Toxicology Program to assess the effects of long-term exposure to 
radiofrequency energy in rats and mice.
4 The study allows for precise 
control over the exposure, as well as a “thorough evaluation for the 
presence of tumors, not just of the brain, but throughout the entire 
body,” says program associate director John Bucher.
The  other  two  studies  are  epidemiologic.  The  case–control 
MOBI-KIDS study was launched last year in 13 countries to inves-
tigate potential risk factors for brain tumors in children, including 
cell phone use.5 Children’s rates of brain cancers have been rising in 
recent years, according to the study’s organizers, who hope to recruit 
approximately 2,000 brain cancer patients and matched controls. The 
COSMOS cohort study, launched in April with the specific goal of 
studying health effects of cell phone use, aims to recruit more than 
250,000 people in five European countries and follow them for up 
to 30 years.6
Kellyn S. Betts has written about environmental contaminants, hazards, and technology 
for  solving  environmental  problems  for  publications  including  EHP  and  Environmental 
Science & Technology for more than a dozen years.
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An advisory panel to the FDA has 
recommended restrictions on the 
use of tanning beds by teenagers. 